Evidence map›Paper›PMID 26196386›Full record

ArticlePLoS neglected tropical diseases2015

Mapping of Schistosomiasis and Soil-Transmitted Helminths in Namibia: The First Large-Scale Protocol to Formally Include Rapid Diagnostic Tests.

José Carlos Sousa-Figueiredo, Michelle C Stanton, Stark Katokele, Moses Arinaitwe, Moses Adriko, Lexi Balfour, Mark Reiff, Warren Lancaster, Bruce H Noden, Ronnie Bock and 1 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Refining Diagnosis ofFrontiers in immunology · 2018
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Schistosomiasis with a Focus on Africa.Tropical medicine and infectious disease · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

José Carlos Sousa-FigueiredoCentro de Investigação em Saúde de Angola (Health Research Center in Angola), Rua direita do Caxito, Hospital Provincial, Bengo, Angola; Department of Life Sciences, Natural History Museum, Wolfson Wellcome Biomedical Laboratories, London, United Kingdom.
Michelle C StantonDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Stark KatokeleNamibia Ministry of Health and Social Services, Windhoek, Namibia.
Moses ArinaitweVector Control Division, Ministry of Health, Kampala, Uganda.
Moses AdrikoVector Control Division, Ministry of Health, Kampala, Uganda.
Lexi BalfourThe END Fund, New York, New York, United States of America.
Mark ReiffThe END Fund, New York, New York, United States of America.
Warren LancasterThe END Fund, New York, New York, United States of America.
Bruce H NodenDepartment of Entomology & Plant Pathology, Oklahoma State University, Stillwater, Oklahoma, United States of America.
Ronnie BockDepartment of Biological Sciences, University of Namibia, Windhoek, Namibia.
J Russell StothardDepartment of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine · GBMinistry of Health · UGMinistry of Health and Social Services · NANatural History Museum · GBOklahoma State University · USUniversity of Namibia · NA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNamibia is now ready to begin mass drug administration of praziquantel and albendazole against schistosomiasis and soil-transmitted helminths, respectively. Although historical data identifies areas of transmission of these neglected tropical diseases (NTDs), there is a need to update epidemiological data. For this reason, Namibia adopted a new protocol for mapping of schistosomiasis and geohelminths, formally integrating rapid diagnostic tests (RDTs) for infections and morbidity. In this article, we explain the protocol in detail, and introduce the concept of 'mapping resolution', as well as present results and treatment recommendations for northern Namibia. METHODS/FINDINGS/

interpretationThis new protocol allowed a large sample to be surveyed (N = 17,896 children from 299 schools) at relatively low cost (7 USD per person mapped) and very quickly (28 working days). All children were analysed by RDTs, but only a sub-sample was also diagnosed by light microscopy. Overall prevalence of schistosomiasis in the surveyed areas was 9.0%, highly associated with poorer access to potable water (OR = 1.5, P<0.001) and defective (OR = 1.2, P<0.001) or absent sanitation infrastructure (OR = 2.0, P<0.001). Overall prevalence of geohelminths, more particularly hookworm infection, was 12.2%, highly associated with presence of faecal occult blood (OR = 1.9, P<0.001). Prevalence maps were produced and hot spots identified to better guide the national programme in drug administration, as well as targeted improvements in water, sanitation and hygiene. The RDTs employed (circulating cathodic antigen and microhaematuria for Schistosoma mansoni and S. haematobium, respectively) performed well, with sensitivities above 80% and specificities above 95%. CONCLUSION/SIGNIFICANCE: This protocol is cost-effective and sensitive to budget limitations and the potential economic and logistical strains placed on the national Ministries of Health. Here we present a high resolution map of disease prevalence levels, and treatment regimens are recommended.

Indexed as

AdolescentAnimalsChildCohort StudiesDiagnostic Tests, RoutineFecesFemaleHumansMaleNamibiaSchistosomaSchistosomiasisSoilYoung AdultSoil

Identifiers

PMID26196386
PMCPMC4509651
OpenAlexW1022221457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.